不同结构的磷酸盐对凝胶体系中草酸钙晶体物相和相组成的影响

泌尿系结石的形成是一种病理性生物矿化过程，不同地区的结石发病率在3％～15％之间。且50％(美国)至80％(中国)的人会复发。结石中约70％以上为草酸钙(CaC2O4)结石。CaC2O4结石的形成与其热力学(过饱和度)和动力学(成核、生长和聚集)因素有关。由于结石患者尿液和正常人尿液中     

粘液素对草酸钙晶体生长的影响

泌尿系结石是一种常见疾病。在70％以上的结石中,草酸钙(CaOxa)单独或和其它钙盐共同为主要成分。一般认为正常人不形成尿石是其尿液中存在的抑制剂抑制了CaOxa晶体的成核、生长、聚集或固相转化。     

不同介质凝胶体系中草酸钙结晶的研究

研究了五种不同介质（水、氯化钠、合成尿、正常人尿液和尿石患者尿液）的凝胶体系中草酸钙（CaC2O4）晶体的生长,及各种体系中防石药物柠檬酸钾（K3cit）对CaC2O4生长的影响.没有加K3cit时,CaC2O4晶体以一水草酸钙（calcium oxalate monohydrate, COM）为主要物相,但在氯化钠和合成尿的凝胶体系中同时出现了二水草酸钙（calcium oxalate dihydrate, COD）和三水草酸钙（calcium oxalate trihydrate, COT）,肾结石患者尿液中出现COD,而正常人尿液中没有COD和COT生成.加入K3cit后,水、氯化钠和合成尿介质的凝胶体系中,COT的含量显著增加,患者尿液中产生大量COD,而正常人尿液中出现了少量的COD和极个别的COT.COT的增加与低温、体系中高的离子强度及金属离子等因素有关.K3cit具有诱导COD和COT的生成、减小COM晶体比表面积的作用,从而有利于防治草酸钙结石的形成.     

琼脂凝胶中形成铬酸铅周期性沉淀的机理研究

选择硝酸铅和铬酸钾作为相互扩散的反应物以形成铬酸铅在琼脂凝胶中的周期性沉淀．分别在光照和黑暗中对六种不同浓度的硝酸铅溶液进行了实验．根据实验现象对周期性沉淀的形成提出了可能的机理．认为光辐射可使铬酸铅部分电离，从而减慢了胶核成长速率，有利于汇聚成带．     

凝胶体系中羧酸对草酸钙结晶的影响

羧酸是泌尿系结石形成的抑制剂。本文采用双扩散法考察凝胶体系中一元羧酸HAc、二元羧酸酒石酸、三元羧酸柠檬酸和四元羧酸EDTA对草酸钙(CaOx)结晶的影响。HAc没有抑制作用。酒石酸和柠檬酸能够改变一水草酸钙(COM)晶体的形貌，并抑制草酸钙晶体二维生长，这种抑制作用随时间的增加而增强。EDTA使COM晶体在长度方向生长更快，而在宽度和厚度上生长更慢。随着结晶温度的降低，形成草酸钙晶体的时间增加，且二水草酸钙(COD)的比例增加。在5℃的低温条件下，添加有二元、三元和四元羧酸的CaOx结晶中，COD成为主要的物相。     

二水草酸钙的形成及其对尿路结石的防治

二水草酸钙(COD)是泌尿系结石的主要成分之一,其成核、生长和聚集过程与尿石的形成密切相关。本文结合我们近年来的工作,综述了生物膜及其模拟膜对COD的调控作用,尿大分子、焦磷酸盐、多磷酸盐、柠檬酸、酒石酸及表面活性剂等尿小分子的诱导作用,过饱和度、化学计量条件、pH值、离子强度、温度等体系参数对COD形成的影响;讨论了COD的形貌、晶面电荷及其与细胞膜粘附的研究进展。从临床上预防和治疗草酸钙结石的角度,综述了有利于COD形成的因素。     

乌梅提取液对草酸钙晶体生长的抑制作用研究

本文研究了水体系中加入乌梅提取液对草酸钙晶体生长的抑制作用,通过FTIR、SEM及XRD等测试方法对所得晶体进行表征。结果表明,不加乌梅提取液的体系中形成的晶体为一水合草酸钙(COM)晶体,加入乌梅提取液后,形成的是二水合草酸钙(COD)晶体,而且COD晶体的尺寸随着乌梅提取液浓度的增大而减小,直至消失,这说明乌梅提取液具有抑制草酸钙晶体生长的作用,且这种抑制作用随乌梅浓度的增大而增大。本文还通过电导率法研究了草酸钙晶体生长的动力学过程,发现乌梅提取液主要能抑制草酸钙晶体的成核过程。     

硅凝胶体系中不同结构羧酸钾对草酸钙结晶的影响

采用扫描电子显微镜(SEM)和X射线衍射(XRD)方法研究了硅凝胶体系中不同种类羧酸钾对草酸钙(CaC₂O₄)晶体生长的调控作用. 加入一元醋酸钾(KOAc)只生成一水草酸钙(COM)晶体; 三元柠檬酸钾(K₃Cit)和四元乙二胺四乙酸二钾(K₂EDTA)可诱导二水草酸钙(COD)形成, 且随着其浓度增加, 对COD的诱导能力增加, 而二元酒石酸钾(K₂Tart)同时诱导了COM, COD和三水草酸钙(COT)生成. 随着结晶温度降低, 多元酸钾可以进一步减小COM晶体的比表面积, 增加COD的百分含量, 但K₂Tart诱导COT的能力减弱. 由于诱导COD和COT晶体形成、减小COM的比表面积均有利于防止草酸钙尿石的形成, 因此, 多元羧酸钾可用于草酸钙结石的预防和治疗.     

过饱和度、反应物化学计量比及离子强度对草酸钙晶体生长的影响

肾结石是一种普遍的疾病,全球的发病率约为10%,且其复发率高。2003年欧洲的一项统计表明,尿石患者第一次复发率为40%[1]。草酸钙(CaOxa)是肾结石的主要成分,其体外模拟引起了人们广泛的关注[2,3]。然而,普通溶液体系的模拟环境不能充分反映尿石的形成环境,用类似细胞膜的有序分     

脂质体中不同种类羧酸钾对草酸钙晶体生长的调控作用

首次研究了狼磷脂-水脂质体中不同种类羧酯钾对草酸钙晶体生长的调控作用 。加入一元DAc只诱导一水草酸钙（COM）生成。二元K_2tart在其浓度大于1. 0mmol/L时可以诱导三水草酸钙（COT）生成。而加入三元的K_3cit和四元的 K_2edta后， 在不同的浓度下，可以分别诱导COM，二水草酸钙（COD）和COT的生 成。在低浓度（—3.3-17mmol/L）范围，， COD含量达到100%；而在较高浓度(＞ 17mmol/L)时，COD减少，COT含量增加。在不同的浓度区间，无论是COM含量减少， 还是COT含量增加，或者是COD含量的先增加后减少，均与该羧酸钾浓度的对数呈线 性关系。不同羧酯钾抑制COM生长并诱导COD形成的能力顺序为：K_3cit＞K_2edta ＞＞K_2tart-KAC,诱导COT生长的能力顺序为：K_2tart＞＞K_3cit＞K_2edta＞＞ KAc.由此推测抑制草酸钙结石形成的潜在效率依次为：K_3cit＞K_2edta＞＞ K_2tart＞＞KAc.     

Simulation of calcium oxalate stone in vitro

Urolithiasis constitutes a serious health problem that affects a significant section of mankind. Between 3% and 14% of the population, depending on the geographical region, suffer from this illness[1]. For example, the incidence of urolithiasis in Florida in the United States of America was 15.7 in 100000 people and increased to 20.8 in 1996. Urolithiasis remains a major medical prob-lem in China, especially in Guangdong Province. A survey in 1997 in Shenzhen City, the most southern city i…     

Effects of temperature and sodium carboxylate additives on mineralization of calcium oxalate in silica gel systems

Urolithiasis remains a major medical problem in China, especially in Guangdong Province in the southest of China[1]. A survey in Shenzhen city, the most southern city in China, showed the incidence of renal calculus was 4.87%, being 6.12% in the males and 4.07% in the females[2]. The prevalence of renal calculus has been more as the age advances and in the male population and so was in the less-educated population. The recurrence rate is more than 80%, with a moderate improvement by conventi…     

Simulation of calcium oxalate stone <Emphasis Type="Italic">in vitro</Emphasis>

Crystallization of calcium oxalate is studied mainly in the diluted healthy urine using scanning electron microscopy (SEM), and is compared with the crystallization in the diluted pathological urine. It suggests that the average sizes of calcium oxalate crystals are not in direct proportion to the concentrations of Ca²⁺ and Ox^2- ions. Only in the concentration range of 0.60-0.90 mmol/L can larger size of CaOx crystals appear. When the concentrations of Ca²⁺ and Ox^2- ions are 1.20, 0.80, 0.60, 0.30 and 0.15 mmol/L in the healthy urine, the average sizes of calcium oxalate crystallites are 9.5 X 6.5, 20.0 X 13.5 and 15.0 jj,m X 10.0 jj,m, respectively, for the former three samples after 6 d crystallization. No crystal appears even after 30 d crystallization for the samples of concentrations of 0.30 and 0.15 mmol/L due to their low supersaturations. The results theoretically explain why the probability of stone forming is clinically not in direct proportion to the concentrations of Ca²⁺ and Ox^2- ions. Laser scattering technology also confirms this point. The reason why healthy human has no risk of urinary stone but stone-formers have is that there are more urinary macromolecules in healthy human urines than that in stone-forming urines. These macromolecules may control the transformation in CaOx crystal structure from monohydrate cal-cium oxalate (COM) to dihydrate calcium oxalate (COD). COD has a weaker affinity for renal tubule cell membranes than COM. No remarkable effect of the crystallization time is observed on the crystal morphology of CaOx. All the crystals are obtuse hexagon. However, the sizes and the number of CaOx crystals can be affected by the crystallization time. In the early stage of crystalli-zation (1-6 d), the sizes of CaOx crystals increase and the number of crystal particles changes little as increasing the crystallization time due to growth control. In the middle and late stages (6-30 d), the number of crystals increases markedly while the growth rate changes little due to the nucleation control.     

The effects of polyelectrolytes on the inhibition and aggregation of calcium oxalate crystallization

The influence of polyelectrolytes with different architecture on spontaneous batch crystallization of calcium oxalate was investigated. A series of acidic acrylate block copolymers were been made, by radical polymerization, with defined molecular weight and structure. Radical polymerization of acrylic acid (AA) was carried out in the presence of α‐thiopolyethylene glycol monomethylether as a chain transfer agent to produce poly(ethylene glycolblockacrylic acid) copolymers. Poly(ethylene glycol) (PEG) block length in the copolymers was controlled by using three different molecular weight chain transfer agents (M_n = 350, 750 and 2000 g/mol). The presence of copolymers inhibited the crystal growth of calcium oxalate possibly through adsorption onto the active growth sites for crystal growth due to the charge and hydrophilic effects. Copyright © 2006 John Wiley & Sons, Ltd.     

柠檬酸钾和pH对单分子膜诱导草酸钙晶体生长的影响

研究了柠檬酸钾(K3cit)和pH对硬脂酸(SA)单分子膜诱导下一水草酸钙(COM)晶体生长的影响。当K3cit浓度c(K3cit)≤0．03mmol／L时，表面压(π)减小使COM尺寸变大；c(K3cit)=0．1mmol／L时，π压变化对COM尺寸影响不大，表明在较高的K3cit浓度下COM生长过程中晶格匹配不是主要控制因素。当c(K3cit)≤0．03mmol／L时，随着K3cit浓度增大，单分子膜下COM变薄。当c(K3cit)≥0．3mmol／L时，K3cit强烈地抑制COM的生长。pH的变化改变了柠檬酸不同物种的分布情况，从而影响COM晶面的生长。在pH=12时诱导了二水草酸钙(COD)晶体的生长，归因于K3cit对COD的诱导作用和高pH条件下SA单分子膜／水界面高的Ca^2 ／Oxa^2-摩尔比。